Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine

Shamaila Ashraf, Wei Kong, Shifeng Wang, Jiseon Yang, Roy Curtiss

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Orally administered recombinant attenuated Salmonella vaccines (RASVs) elicit humoral and mucosal immune responses against the immunizing antigen. The challenge in developing an effective vaccine against a virus or an intracellular bacterium delivered by RASVs is to introduce the protective antigen inside the host cell cytoplasm for presentation to MHC-I molecules for an efficient cell mediated immune response. To target the influenza nucleoprotein (NP) into the host cell cytosol, we constructed a regulated delayed lysis in vivo RASV strain χ11246(pYA4858) encoding influenza NP with a chromosomal deletion of the sifA gene to enable it to escape from the endosome prior to lysis. Oral immunization of mice with χ11246(pYA4858) (SifA-) with 3 booster immunizations resulted in complete protection (100%) against a lethal influenza virus (rWSN) challenge (100 LD50) compared to 25% survival of mice immunized with the isogenic χ11017(pYA4858) (SifA+) strain. Reducing the number of booster immunizations with χ11246(pYA4858) from 3 to 2 resulted in 66% survival of mice challenged with rWSN (100 LD50). Immunization with χ11246(pYA4858) via different routes provided protection in 80% orally, 100% intranasally and 100% intraperitoneally immunized mice against rWSN (100 LD50). A Th1 type immune response was elicited against influenza NP in all experiments. IFN-γ secreting NP147-155 specific T cells were not found to be correlated with protection. The role of antigen-specific CD8+ T cells remains to be determined. To conclude, we showed that Salmonella can be designed to deliver antigen(s) to the host cell cytosol for presumably class I presentation for the induction of protective immune responses.

Original languageEnglish (US)
Pages (from-to)3990-4002
Number of pages13
JournalVaccine
Volume29
Issue number23
DOIs
StatePublished - May 23 2011

Fingerprint

Salmonella Vaccines
Attenuated Vaccines
Synthetic Vaccines
nucleoproteins
Nucleoproteins
influenza
Human Influenza
Lethal Dose 50
Salmonella
Vaccination
lethal dose 50
vaccination
vaccines
antigens
Secondary Immunization
mice
Antigens
cytosol
Cytosol
Immunization

Keywords

  • Influenza
  • Nucleoprotein
  • RASV
  • Salmonella
  • SifA

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine. / Ashraf, Shamaila; Kong, Wei; Wang, Shifeng; Yang, Jiseon; Curtiss, Roy.

In: Vaccine, Vol. 29, No. 23, 23.05.2011, p. 3990-4002.

Research output: Contribution to journalArticle

Ashraf, Shamaila ; Kong, Wei ; Wang, Shifeng ; Yang, Jiseon ; Curtiss, Roy. / Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine. In: Vaccine. 2011 ; Vol. 29, No. 23. pp. 3990-4002.
@article{c458c07c29de41779ab7ad78ca13bc66,
title = "Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine",
abstract = "Orally administered recombinant attenuated Salmonella vaccines (RASVs) elicit humoral and mucosal immune responses against the immunizing antigen. The challenge in developing an effective vaccine against a virus or an intracellular bacterium delivered by RASVs is to introduce the protective antigen inside the host cell cytoplasm for presentation to MHC-I molecules for an efficient cell mediated immune response. To target the influenza nucleoprotein (NP) into the host cell cytosol, we constructed a regulated delayed lysis in vivo RASV strain χ11246(pYA4858) encoding influenza NP with a chromosomal deletion of the sifA gene to enable it to escape from the endosome prior to lysis. Oral immunization of mice with χ11246(pYA4858) (SifA-) with 3 booster immunizations resulted in complete protection (100{\%}) against a lethal influenza virus (rWSN) challenge (100 LD50) compared to 25{\%} survival of mice immunized with the isogenic χ11017(pYA4858) (SifA+) strain. Reducing the number of booster immunizations with χ11246(pYA4858) from 3 to 2 resulted in 66{\%} survival of mice challenged with rWSN (100 LD50). Immunization with χ11246(pYA4858) via different routes provided protection in 80{\%} orally, 100{\%} intranasally and 100{\%} intraperitoneally immunized mice against rWSN (100 LD50). A Th1 type immune response was elicited against influenza NP in all experiments. IFN-γ secreting NP147-155 specific T cells were not found to be correlated with protection. The role of antigen-specific CD8+ T cells remains to be determined. To conclude, we showed that Salmonella can be designed to deliver antigen(s) to the host cell cytosol for presumably class I presentation for the induction of protective immune responses.",
keywords = "Influenza, Nucleoprotein, RASV, Salmonella, SifA",
author = "Shamaila Ashraf and Wei Kong and Shifeng Wang and Jiseon Yang and Roy Curtiss",
year = "2011",
month = "5",
day = "23",
doi = "10.1016/j.vaccine.2011.03.066",
language = "English (US)",
volume = "29",
pages = "3990--4002",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "23",

}

TY - JOUR

T1 - Protective cellular responses elicited by vaccination with influenza nucleoprotein delivered by a live recombinant attenuated Salmonella vaccine

AU - Ashraf, Shamaila

AU - Kong, Wei

AU - Wang, Shifeng

AU - Yang, Jiseon

AU - Curtiss, Roy

PY - 2011/5/23

Y1 - 2011/5/23

N2 - Orally administered recombinant attenuated Salmonella vaccines (RASVs) elicit humoral and mucosal immune responses against the immunizing antigen. The challenge in developing an effective vaccine against a virus or an intracellular bacterium delivered by RASVs is to introduce the protective antigen inside the host cell cytoplasm for presentation to MHC-I molecules for an efficient cell mediated immune response. To target the influenza nucleoprotein (NP) into the host cell cytosol, we constructed a regulated delayed lysis in vivo RASV strain χ11246(pYA4858) encoding influenza NP with a chromosomal deletion of the sifA gene to enable it to escape from the endosome prior to lysis. Oral immunization of mice with χ11246(pYA4858) (SifA-) with 3 booster immunizations resulted in complete protection (100%) against a lethal influenza virus (rWSN) challenge (100 LD50) compared to 25% survival of mice immunized with the isogenic χ11017(pYA4858) (SifA+) strain. Reducing the number of booster immunizations with χ11246(pYA4858) from 3 to 2 resulted in 66% survival of mice challenged with rWSN (100 LD50). Immunization with χ11246(pYA4858) via different routes provided protection in 80% orally, 100% intranasally and 100% intraperitoneally immunized mice against rWSN (100 LD50). A Th1 type immune response was elicited against influenza NP in all experiments. IFN-γ secreting NP147-155 specific T cells were not found to be correlated with protection. The role of antigen-specific CD8+ T cells remains to be determined. To conclude, we showed that Salmonella can be designed to deliver antigen(s) to the host cell cytosol for presumably class I presentation for the induction of protective immune responses.

AB - Orally administered recombinant attenuated Salmonella vaccines (RASVs) elicit humoral and mucosal immune responses against the immunizing antigen. The challenge in developing an effective vaccine against a virus or an intracellular bacterium delivered by RASVs is to introduce the protective antigen inside the host cell cytoplasm for presentation to MHC-I molecules for an efficient cell mediated immune response. To target the influenza nucleoprotein (NP) into the host cell cytosol, we constructed a regulated delayed lysis in vivo RASV strain χ11246(pYA4858) encoding influenza NP with a chromosomal deletion of the sifA gene to enable it to escape from the endosome prior to lysis. Oral immunization of mice with χ11246(pYA4858) (SifA-) with 3 booster immunizations resulted in complete protection (100%) against a lethal influenza virus (rWSN) challenge (100 LD50) compared to 25% survival of mice immunized with the isogenic χ11017(pYA4858) (SifA+) strain. Reducing the number of booster immunizations with χ11246(pYA4858) from 3 to 2 resulted in 66% survival of mice challenged with rWSN (100 LD50). Immunization with χ11246(pYA4858) via different routes provided protection in 80% orally, 100% intranasally and 100% intraperitoneally immunized mice against rWSN (100 LD50). A Th1 type immune response was elicited against influenza NP in all experiments. IFN-γ secreting NP147-155 specific T cells were not found to be correlated with protection. The role of antigen-specific CD8+ T cells remains to be determined. To conclude, we showed that Salmonella can be designed to deliver antigen(s) to the host cell cytosol for presumably class I presentation for the induction of protective immune responses.

KW - Influenza

KW - Nucleoprotein

KW - RASV

KW - Salmonella

KW - SifA

UR - http://www.scopus.com/inward/record.url?scp=79955671015&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955671015&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2011.03.066

DO - 10.1016/j.vaccine.2011.03.066

M3 - Article

C2 - 21466806

AN - SCOPUS:79955671015

VL - 29

SP - 3990

EP - 4002

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 23

ER -